Chicken Egg Yolk Antibodies (IgYs) Block the Binding of Multiple SARS-C0V-2 Spike Protein Variants to Human ACE2

Shuangshi Wei et al.

The SARS-CoV-2 virus is still spreading worldwide, and there is an urgent need to effectively prevent and control this pandemic. This study evaluated the potential efficacy of Egg Yolk Antibodies (IgY) as a neutralizing agent against the SARS-CoV-2. We investigated the neutralizing effect of anti-spike-S1 IgYs on the SARS-CoV-2 pseudovirus, as well as its inhibitory effect on the binding of the coronavirus spike protein mutants to human ACE2. Our results show that the anti-Spike-S1 IgYs showed significant neutralizing potency against SARS-CoV-2 pseudovirus, various spike protein mutants, and even SARS-CoV in vitro. It might be a feasible tool for the prevention and control of ongoing COVID-19.

Latest articles

In mid-June 2024 our close friends and allies at Vaccine Choice Canada...
Image caption: Dr. Rochagné Kilian during a recent interview with Dr. Peter...
Recently we drove 220 kilometers return trip to visit a longtime gardening...
I am a 70 year old medical doctor who has practiced medicine...

Thank you!

Thank you for your membership application. As soon as your payment has been received your membership will be activated and you will be informed via email.

Thank you.

Thank you!

The form has been submitted successfully!